{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:34:35Z","timestamp":1783953275613,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neuroscience.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T01:08:20Z","timestamp":1723165700000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Different neurotoxicity and seeding activity between \u03b1-synuclein oligomers formed in plasma of patients with Parkinson\u2019s disease and multiple system atrophy"],"prefix":"10.1016","volume":"557","author":[{"given":"Hanjiang","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.08.006_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1197853","article-title":"Alpha synuclein post translational modifications: Potential targets for Parkinson's disease therapy?","volume":"16","author":"Brembati","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0010","doi-asserted-by":"crossref","unstructured":"Carter RJ, Morton J, Dunnett SB (2001) Motor coordination and balance in rodents. Curr Protoc Neurosci Chapter 8:Unit 8 12.","DOI":"10.1002\/0471142301.ns0812s15"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuroscience.2015.05.035","article-title":"alpha-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with reduced inward current and Ca(2+) influx upon NMDA stimulation","volume":"300","author":"Chen","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0020","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1523\/JNEUROSCI.12-09-03392.1992","article-title":"A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin","volume":"12","author":"Crawford","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0025","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mds.25927","article-title":"Multiple system atrophy: prognostic indicators of survival","volume":"29","author":"Figueroa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065914","article-title":"Alpha Synuclein: Neurodegeneration and Inflammation","volume":"24","author":"Forloni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0035","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1373\/clinchem.2006.076364","article-title":"Human plasma ATP concentration","volume":"53","author":"Gorman","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000113678","article-title":"Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness","volume":"5","author":"Hornykiewicz","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.14802\/jmd.21029","article-title":"Increased mortality in young-onset Parkinson's disease","volume":"14","author":"Hustad","year":"2021","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0000000000007949","article-title":"Spinal cord alpha-synuclein deposition associated with myoclonus in patients with MSA-C","volume":"93","author":"Hwang","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0060","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","article-title":"Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice","volume":"7","author":"Karampetsou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0065","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.3390\/ijms23116216","article-title":"Pathogenic impact of alpha-Synuclein phosphorylation and its kinases in alpha-Synucleinopathies","volume":"23","author":"Kawahata","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of Synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0075","article-title":"Receptor-dependent endocytosis mediates alpha-Synuclein oligomer transport into red blood cells","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0080","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0095","doi-asserted-by":"crossref","first-page":"37130","DOI":"10.1038\/srep37130","article-title":"Phosphorylation induces distinct alpha-synuclein strain formation","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0105","doi-asserted-by":"crossref","first-page":"e1209","DOI":"10.1038\/cddis.2014.175","article-title":"Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation","volume":"5","author":"Perez-Revuelta","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0110","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nbd.2018.03.001","article-title":"Inflammation kinase PKR phosphorylates alpha-synuclein and causes alpha-synuclein-dependent cell death","volume":"115","author":"Reimer","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-8820-4_2","article-title":"Ultrasensitive RT-QuIC seed amplification assays for disease-associated Tau, alpha-Synuclein, and prion aggregates","volume":"1873","author":"Saijo","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood-brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0140","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies","volume":"139","author":"Van der Perren","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0145","article-title":"Blood plasma of patients with Parkinson's disease increases alpha-Synuclein aggregation and neurotoxicity","volume":"2016","author":"Wang","year":"2016","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0150","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson's disease and multiple system atrophy have distinct alpha-synuclein seed characteristics","volume":"294","author":"Yamasaki","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0160","first-page":"1995","article-title":"alpha-Syn oligomers incubated with Parkinson's disease plasma promote neuron damage","volume":"13","author":"Yang","year":"2020","journal-title":"Int. J. Clin. Exp. Path."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0165","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00018-016-2411-y","article-title":"Synucleinopathies: Common features and hippocampal manifestations","volume":"74","author":"Yang","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2004.05.118","article-title":"Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells","volume":"367","author":"Yu","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2006.12.028","article-title":"Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody","volume":"145","author":"Yu","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2024.08.006_b0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","article-title":"Post-translational modifications of soluble alpha-synuclein regulate the amplification of pathological alpha-synuclein","volume":"26","author":"Zhang","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.08.006_b0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12264-017-0179-1","article-title":"Age-dependent alpha-Synuclein accumulation and phosphorylation in the enteric nervous system in a transgenic mouse model of Parkinson's disease","volume":"33","author":"Zhong","year":"2017","journal-title":"Neurosci. Bull."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224003865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224003865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:30:32Z","timestamp":1725381032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224003865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"alternative-id":["S0306452224003865"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.08.006","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different neurotoxicity and seeding activity between \u03b1-synuclein oligomers formed in plasma of patients with Parkinson\u2019s disease and multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}